ANIP CapEx to Revenue

Ani Pharmaceuticals Inc · CapEx to Revenue

ANIP logo

ANIP CapEx to Revenue

Current (TTM)3.07%
ANIP CapEx/Revenue (101.56% → 3.07%)
High-resolution chart · PNG

ANIP capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Ani Pharmaceuticals Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
3.8853%
2.7594%
3.8025%
5.2009%
10.9366%
32.7723%
13.3379%
5.4133%
61.0675%
115.89%
42.8225%
63.8807%
0.6349%
26.5651%
165.4391%
2.5641%
13.173%
17.2215%
5.9685%
0.2719%
26.0947%
132.5065%
13.5356%
1.3759%
4.9637%
0%
0%
101.5626%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.